"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA
CopyKey data
Status
KRS number
REGON
NIP/VAT code
VAT registration date
VAT status
Bankruptcy proceedings
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA
Contacts
Registered address
Website
-B
HighReliability
Incorporation date
20/06/2011Share capital
No dataPrimary activity
Veterinary activities (75.00.Z - PKD 2007)Representatives
0Representatives rights
REPREZENTACJA JEDNOOSOBOWARepresentatives
Business linkages
Compliance screening
Check whether your partner is listed in sanctions or PEP registers, or linked to negative public information or law enforcement reports. Ensure business safety and compliance.People
Representatives
Person | Title |
|---|---|
- | - |
Persons with Significant Control
Financial ratios
Net Profit (zł)
2,644,385Net Profit (zł)
2,644,385Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
| Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2024 |
|---|
| 15,660,271 |
| 2,644,385 |
| 2,644,385 |
| 0.16 |
| 1.60 |
| 16.89 |
| 2,659,385 |
| 4,311,243 |
| 0 |
| 81,974 |
| 2024 |
|---|
| 15,660,271 |
| 2,644,385 |
| 2,644,385 |
| 0.16 |
| 1.60 |
| 16.89 |
| 2,659,385 |
| 4,311,243 |
| 0 |
| 81,974 |
Turnover (zł)
2024
Turnover (zł)
15,660,271 zł- *
Profit before tax (zł)
2,644,385 zł- *
Net Profit (zł)
2,644,385 zł- *
Working capital requirement (%)
0.16 - *
Liquidity ratio
1.60 - *
Net profitability (%)
16.89 %- *
Equity (zł)
2,659,385 zł- *
Current liabilities (zł)
4,311,243 zł- *
Non current liabilities (zł)
0 zł- *
Non-current Assets (zł)
81,974 zł- *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order reportCreditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA Documents
Date | Description |
|---|---|
10/07/2025 | OD 01.01.2024 DO 31.12.2024 |
Frequently Asked Questions
What is the current status of "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA is currently Active. It was registered on 20/06/2011.
Where is "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA located?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA is registered at UL. DĄBROWSZCZAKÓW 39, 10-542, OLSZTYN, POLSKA.
What does "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA do?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA operates in the Veterinary activities (75.00.Z - PKD 2007) sector.
What is the annual turnover of "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA reported a turnover of 15,660,271 PLN in 2024.
What is the net profit of "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA reported a net profit of 2,644,385 PLN in 2024.
Is "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA a reliable company?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA Pre-Score* rating is B, which indicates a high level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.Does "ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA have any unpaid debts?
"ANIMAL PHARMA OPOLE - KRUSZYŃSKI, PIECZKOWSKI, RAPKOWSKI" SPÓŁKA JAWNA has no recorded unpaid debts.